Incidence of invasive pneumococcal disease and distribution of capsular types of pneumococci in Denmark, 1989-94

Epidemiology and Infection

Volumn 117, Issue 3, 1996, Pages 411-416

  Nielsen, S V ^a,b   Henrichsen, J ^a  

^a WHO REGIONAL OFFICE FOR EUROPE   (Denmark)

^b STATENS SERUM INSTITUT   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

PENICILLIN G;

ARTICLE; BLOOD ANALYSIS; CEREBROSPINAL FLUID ANALYSIS; DRUG SENSITIVITY; ENZYME ACTIVITY; HUMAN; PENICILLIN RESISTANCE; REGRESSION ANALYSIS; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE;

EID: 0029769702     PISSN: 09502688     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0950268800059057     Document Type: Article

References (30)

1. Lund E, Henrichsen J. Laboratory diagnosis, serology and epidemiology of Streptococcus pneumoniae. In: Bergan T, Norris JR, eds. Methods in microbiology 1978; 12: 241-62.
2. Austrian R, Boettger C, Dole M, Fairly L, Freid M. Streptococcus pneumoniae type 16A, a hitherto undescribed pneumococcal type. J Clin Microbiol 1985; 22: 127-8.
3. Henrichsen J. Six newly recognized types of Streptococcus pneumoniae. J Clin Microbiol 1995; 33: 2759-62.
4. Robbins JB, Austrian R, Lee CJ, et al. Considerations for formulating the second-generation pneumococcal capsular polysaccharide vaccine with emphasis on the cross-reactive types within groups. J Infect Dis 1983; 148: 1136-59.
5. Steinberg JJ, Levine DS, Desiderio D, Hanna BA. Serotypes of Streptococcus pneumoniae recovered from a large urban hospital population: the Bellevue experience from 1973 to 1984. Lab Med 1988; 19: 741-3.
6. Nielsen SV, Henrichsen J. Capsular types of Streptococcus pneumoniae isolated from blood and CSF during 1982-87. Clin Infect Dis 1992; 15: 794-8.
7. Broome CV, Facklam RR. Epidemiology of clinically significant isolates of Streptococcus pneumoniae in the United States. Rev Infect Dis 1981; 3: 277-80.
8. Klugman KP, Koornhof HJ. Drug resistance patterns and serogroups or serotypes of pneumococcal isolates from cerebrospinal fluid or blood, 1979-1986. J Infect Dis 1988; 158: 956-64.
9. Parkinson AJ, Davidson M, Fitzgerald MA, Bulkow LR, Parks DJ. Serotype distribution and antimicrobial resistance patterns of invasive isolates of Streptococcus pneumoniae: Alaska 1986-1990. J Infect Dis 1994; 170: 461-4.
10. Barry MA, Craven DE, Finland M. Serotypes of Streptococcus pneumoniae isolated from blood cultures at Boston City Hospital between 1979 and 1982. J Infect Dis 1984; 149: 448-52.
11. Klugman KP. Pneumococcal resistance to antibiotics. Clin Microbiol Rev 1990; 3: 171-96.
12. Appelbaum PC. Antimicrobial resistance in Streptococcus pneumoniae: an overview. Clin Infect Dis 1992; 15: 77-83.
13. Kristinsson KG, Hjalmaesdottir MA, Steingrimsson O. Increasing penicillin resistance in pneumococci in Iceland. Lancet 1992; 339: 1606-7.
14. Munoz R, Coffey TJ, Daniels M, et al. Intercontinental spread of a multiresistant clone of serotype 23F Streptococcus pneumoniae. J Infect Dis 1991; 164: 302-5.
15. Munoz R, Musser JM, Crain M, et al. Geographic distribution of penicillin-resistant clones of Streptococcus pneumoniae: characterization by penicillin-binding protein profile, surface protein A typing, and multilocus enzyme analysis. Clin Infect Dis 1992; 15: 112-8.
16. Nielsen SV, Henrichsen J. Capsular types and susceptibility to penicillin of pneumococci isolated from cerebrospinal fluid or blood in Denmark, 1983-1988. Scand J Infect Dis 1993; 25: 165-70.
17. Nissinen A, Leinonen M, Huovinen P, et al. Antimicrobial resistance of Streptococcus pneumoniae in Finland, 1987-1990. Clin Infect Dis 1995; 20: 1275-80.
18. Ekdahl K, Kamme C. Increasing resistance to penicillin in Streptococcus pneumoniae in Southern Sweden. Scand J Infect Dis 1994; 26: 301-5.
19. Steinhoff MC. Developing and deploying pneumococcal and Haemophilus vaccines, Lancet 1993; 342: 630-1.
20. Statistical Yearbook. Danmarks Statistik.
21. Robbins JB, Lee CJ, Rastogi SC, Schiffman G, Henrichsen J. Comparative immunogenicity of group 6 pneumococcal type 6A(6) and type 6B(26) capsular polysaccharides. Infect Immun 1979; 26: 1116-22.
22. Henrichsen J. The pneumococcal typing system and pneumococcal surveillance. J Infect 1979; 1: 31-37.
23. Finland M, Barnes MW. Changes in occurrence of capsular serotypes of Streptococcus pneumoniae at Boston City Hospital during selected years between 1935 and 1974. J Clin Microbiol 1977; 5: 154-66.
24. Magnus T, Andersen BM. Serotypes and resistance patterns of Streptococcus pneumoniae causing systemic disease in Northern Norway. Eur J Clin Microbiol Infect Dis 1995; 14: 229-34.
25. Davidson M, Parkinson AJ, Bulkow LR, Fitzgerald MA, Peters HV, Parks DJ. The epidemiology of invasive pneumococcal disease in Alaska 1986-1990 -ethnic differences and opportunities for prevention. J Infect Dis 1994; 170: 368-76.
26. Eskola J, Takala AK, Kela E, Pekkanen E, Kalliokoski R, Leinonen M. Epidemiology of invasive pneumococcal infections in children in Finland. JAMA 1992; 268: 3323-7.
27. Gransden WR, Eykyn SJ, Phillips I. Pneumococcal bacteraemia: 325 episodes diagnosed at St Thomas's Hospital. BMJ 1985; 290: 505-8.
28. Gray BM, Dillon HC. Clinical and epidemiologic studies of pneumococcal infections in children. Ped Infect Dis 1986; 5: 201-7.
29. Shapiro ED, Austrian R. Serotypes responsible for invasive Streptococcus pneumoniae infections among children in Connecticut. J Infect Dis 1994; 169: 212-4.
30. Butler JC, Breiman RF, Lipman HB, Hofmann J, Facklam RR. Serotype distribution of Streptococcus pneumoniae infections among preschool children in the United States, 1978-1994: Implications for development of a conjugate vaccine. J Infect Dis 1995; 171: 885-9.